The Central Board of Secondary Education (CBSE) will conduct the Class 12 Physics exam on February 20, 2026. For many ...

The National Medical Commission has released the NEET UG 2026 syllabus, exclusively based on Class 11 and 12 NCERT textbooks.

The National Medical Commission (NMC) has released the official NEET UG 2026 syllabus, outlining the topics to be covered in ...

A surge of 147% in a single session is an unusual occurrence in biotech — and nearly unprecedented for a company that has spent years trading discreetly under the radar. However, that is precisely ...

Hyderabad woke up to unusually cold weather on Thursday, with temperatures slipping to 7°C within Greater Hyderabad Municipal Corporation (GHMC) limits. (Photo: X/@Hyderabadrains) The cold wave ...

View post: Dickies $50 Heavyweight Fleece Sweatshirts Are Now Just $13 — 74% Off LeBron 23 sneaker introduces a unique crown design wrapping around the midsole. The new "Heat Wave" colorway honors ...

King James is known for having one of the longest sneaker lines in Nike history, and it only seems to get better with time. I’ve said before that ever since the LeBron 20s, his sneakers have been some ...

The cold wave in Telangana is set to continue as India Meteorological Department (IMD) has issued the alert for 12 districts for Friday (December 12, 2025). Under the weather conditions, the lowest of ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

It wasn't hard to be optimistic about the biotech's future, given its excellent news from the lab on Monday. Prognosticators fell over themselves publishing bullish new takes on the company the ...

D-Wave Quantum surged over 50% from November lows despite broader tech market volatility. Evercore ISI initiated coverage with a $44 price target versus current $28. The firm cited D-Wave as a leading ...

Wave Life Sciences Ltd. (NASDAQ: WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE ...